ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TLRY Tilray Brands Inc

1.97
-0.08 (-3.90%)
08 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Tilray Brands Inc NASDAQ:TLRY NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.08 -3.90% 1.97 1.97 1.98 2.08 1.98 2.03 23,305,123 00:59:57

Tilray to Report Fourth Quarter and Full Fiscal Year 2019 Financial Results on March 2, 2020

25/02/2020 9:24pm

Business Wire


Tilray Brands (NASDAQ:TLRY)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Tilray Brands Charts.

Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation, and distribution, announced today it will report results for the fourth quarter and full fiscal year ended December 31, 2019 on Monday, March 2, 2020 after market close.

The Company will host a conference call to discuss these results at 5:00 p.m. ET. Investors interested in participating in the live call can dial 877-489-6528 from the U.S. and 629-228-0736 internationally. A telephone replay will be available approximately two hours after the call concludes through Monday, March 16, 2020, by dialing 855-859-2056 from the U.S., or 404-537-3406 from international locations, and entering confirmation code 8197352.

There will also be a simultaneous, live webcast available on the Investors section of the Company’s website at www.tilray.com. The webcast will be archived for 30 days.

About Tilray®

Tilray (Nasdaq: TLRY) is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in 15 countries spanning five continents.

For further information: Media, Global: Chrissy Roebuck, +1-833-206-8161, news@tilray.com Investors: Rachel Perkins, +1-646-277-1221, rachel.perkins@icrinc.com

1 Year Tilray Brands Chart

1 Year Tilray Brands Chart

1 Month Tilray Brands Chart

1 Month Tilray Brands Chart

Your Recent History

Delayed Upgrade Clock